Abstract:8067 Background: The defective immune system in plasma cell dyscrasia places patients at a higher risk of developing a severe infection, which is one of the leading causes of death in such patients. In an era of a global pandemic, it is essential to protect them against COVID-19, but fewer effective plasma cells lead to a suboptimal response to vaccines. There is still a lack of evidence whether the seroconversion is truly clinically relevant and if patients with plasma cell disorders would benefit from frequ… Show more
“…Dear Editor, We would like to share ideas on the publication 'COVID-19 vaccine immune response in patients with plasma cell dyscrasia: a systematic review'. 1 The purpose of this systematic review was to assess the immunological response to COVID-19 vaccinations in plasma cell dyscrasia patients and provide insights to improve clinical management. The review adhered to PRISMA principles and included nine papers (seven prospective and two retrospective studies) among 59 found via internet database searches.…”
Section: Therapeutic Advances In Vaccines and Immunotherapymentioning
“…Dear Editor, We would like to share ideas on the publication 'COVID-19 vaccine immune response in patients with plasma cell dyscrasia: a systematic review'. 1 The purpose of this systematic review was to assess the immunological response to COVID-19 vaccinations in plasma cell dyscrasia patients and provide insights to improve clinical management. The review adhered to PRISMA principles and included nine papers (seven prospective and two retrospective studies) among 59 found via internet database searches.…”
Section: Therapeutic Advances In Vaccines and Immunotherapymentioning
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.